| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a7ac31dafa9b644bcbf73f79c4695dc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e81bdcd3ffd95e818fc3a6ce42f9c13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4041c1354c860462ab43d9134d142548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f28a095315dac49c72933c8dbc1902d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da6ec93f510bc7b714db3839b6dec48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aef328ca44393e496b579c2db770446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c9ab96ea1f738e58917d5a7c01b2d1c |
| publicationDate |
2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11001588-B2 |
| titleOfInvention |
Activating pyruvate kinase R and mutants thereof |
| abstract |
The disclosure provides chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022087983-A1 |
| priorityDate |
2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |